CareTrust REIT, Inc. (NYSE: CTRE) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
40.39
-0.83-2.01%
News
Down 2.0% — CareTrust REIT Q2 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | - | P/E | 25.92 | EPS (ttm) | 1.59 | Insider Own | 1.54% | Shs Outstand | 236.24M | Perf Week | -1.72% |
| Market Cap | 9.74B | Forward P/E | 25.64 | EPS next Y | 1.61 | Insider Trans | - | Shs Float | 234.30M | Perf Month | 0.88% |
| Enterprise Value | 10.89B | PEG | 0.83 | EPS next Q | - | Inst Own | - | Short Float | 10.18% | Perf Quarter | 4.35% |
| Income | 359.33M | P/S | 17.92 | EPS this Y | -5.27% | Inst Trans | - | Short Ratio | 8.90 | Perf Half Y | 6.76% |
| Sales | 543.45M | P/B | 2.15 | EPS next Y | 7.42% | ROA | 5.99% | Short Interest | 23.84M | Perf YTD | 13.99% |
| Book/sh | - | P/C | 17.93 | EPS next 5Y | 4.13% | ROE | 8.54% | 52W High | 42.74 -5.50% | Perf Year | 26.25% |
| Cash/sh | - | P/FCF | 18.78 | EPS past 3/5Y | 52.81% 21.21% | ROIC | 6.62% | 52W Low | 31.28 29.14% | Perf 3Y | 102.06% |
| Dividend Est. | 1.56 (3.86%) | EV/EBITDA | 20.80 | Sales past 3/5Y | 36.39% 22.07% | Gross Margin | 77.91% | Volatility | 2.27% 2.28% | Perf 5Y | 70.90% |
| Dividend TTM | 1.45 (3.59%) | EV/Sales | 20.05 | EPS Y/Y TTM | 97.50% | Oper. Margin | 73.00% | ATR (14) | 0.99 | Perf 10Y | 186.05% |
| Dividend Ex-Date | Jun 30, 2026 | Quick Ratio | 0.00 | Sales Y/Y TTM | 105.26% | Profit Margin | 65.40% | RSI (14) | 49.04 | Recom | 2.26 |
| Dividend Gr. 3/5Y | 6.80% 6.03% | Current Ratio | 0.00 | EPS Q/Q | -14.29% | SMA20 | -1.48% | Beta | 0.79 | Target Price | 44.50 |
| Payout | 106.91% | Debt/Eq | 0.27 | Sales Q/Q | 98.61% | SMA50 | 2.58% | Rel Volume | 0.71 | Prev Close | 41.22 |
| Employees | 43 | LT Debt/Eq | 0.22 | Earnings | Nov 04 | SMA200 | 6.81% | Avg Volume | 2.74M | Price | 40.39 |
| IPO Date | May 29, 2014 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 1.83% 1.19% | Net Debt/EBITDA | 2.21 | Volume | 1,934,153 | Change | -2.01% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-16-26 | Resumed | Raymond James | Outperform | $39 → $43 |
| Jun-15-26 | Reiterated | BMO Capital | Outperform | $43 → $47 |
| May-29-26 | Reiterated | KeyBanc | Overweight | $40 → $46 |
| May-22-26 | Reiterated | Mizuho Securities | Neutral | $45 |
| Feb-24-26 | Reiterated | RBC Capital | Outperform | $23 → $44 |
| Feb-17-26 | Reiterated | Cantor Fitzgerald | Neutral | $37 → $42 |
| Jan-22-26 | Reiterated | Goldman Sachs | $44 | |
| Jan-09-26 | Upgrade | BMO Capital | Market Perform → Outperform | $43 |
| Jan-08-26 | Reiterated | UBS | Buy | $43 |
| Dec-04-25 | Reiterated | Keybanc | Overweight | $36 → $40 |
Latest News
Aug-07-26
02:54PM
CareTrust REIT, Inc. (CTRE) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-06-26
Aug-06-2609:32PM
06:41PM
04:20PM
Aug-04-26
Aug-04-2603:43AM
Jul-30-26
Jul-30-2609:50AM
Jul-28-26
Jul-24-26
Jul-24-2604:11AM
Jul-23-26
Jul-21-26
Jul-21-2603:07AM
Jul-19-26
Jul-11-26
Jul-06-26
Jun-26-26
Jun-26-2605:55PM
Company
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 543 | 477 | 228 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 120 | 195 | 14 | — | — | — | — | — | — | |
| Gross Profit | 424 | 282 | 215 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | -21 | 0 | 28 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 47 | -38 | 63 | — | — | — | — | — | — | |
| Operating Income | 398 | 320 | 124 | — | — | — | — | — | — | |
| Interest Expense | 50 | 44 | 30 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 17 | 49 | 31 | — | — | — | — | — | — | |
| Net Income Before Taxes | 364 | 325 | 124 | — | — | — | — | — | — | |
| Income Taxes | 3 | 5 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | 355 | 321 | 125 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 356 | 320 | 124 | — | — | — | — | — | — | |
| Net Income | 355 | 321 | 125 | — | — | — | — | — | — | |
| EPS (Recurring) | 1.59 | 1.57 | 0.81 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.59 | 1.57 | 0.81 | — | — | — | — | — | — | |
| EPS (Diluted) | 1.61 | 1.57 | 0.80 | — | — | — | — | — | — | |
| EBITDA | 523 | 462 | 212 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 25.09 | 23.03 | 33.81 | — | — | — | — | — | — | |
| Price To Sales Ratio | 17.41 | 15.46 | 18.39 | — | — | — | — | — | — | |
| Gross Margin | 78.08 | 59.12 | 94.30 | — | — | — | — | — | — | |
| Operating Margin | 73.30 | 67.09 | 54.39 | — | — | — | — | — | — | |
| Net Margin | 65.38 | 67.30 | 54.82 | — | — | — | — | — | — | |
| Shares Outstanding | 234 | 204 | 155 | — | — | — | — | — | — | |
| Market Capitalization | 9,451 | 7,377 | 4,193 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Wagner William M | CFO and Treasurer | Sep 04 '24 | Sale | 29.80 | 35,000 | 1,043,000 | 257,439 | Sep 05 |
| Plumb Spencer G | Director | Mar 13 '20 | Buy | 12.77 | 1,500 | 19,155 | 12,721 | Mar 16 |
| SABIN GARY B | Director | Nov 16 '15 | Buy | 10.25 | 20,000 | 205,000 | 32,160 | Nov 16 |
| Sedgwick David M. | Vice President of Operations | Aug 13 '15 | Buy | 10.50 | 19,000 | 199,500 | 114,422 | Aug 17 |
| Wagner William M | CFO, Secretary and Treasurer | Aug 13 '15 | Buy | 10.50 | 35,000 | 367,500 | 112,635 | Aug 17 |
| Stapley Gregory K. | President, Chairman and CEO | Aug 13 '15 | Buy | 10.50 | 50,000 | 525,000 | 205,015 | Aug 17 |
| Kline Jon D | Director | Aug 13 '15 | Buy | 10.50 | 25,000 | 262,500 | 36,570 | Aug 17 |
| Sedgwick David M. | Vice President of Operations | May 31 '15 | Option Exercise | 0.00 | 5,485 | 0 | 56,071 | Jun 02 |
| Christensen Christopher R. | Director | Jan 13 '15 | Sale | 11.78 | 30,604 | 360,644 | 1,109,170 | Jan 15 |
| Christensen Christopher R. | Director | Jan 12 '15 | Sale | 11.75 | 80,509 | 945,594 | 1,139,774 | Jan 12 |
| Christensen Christopher R. | Director | Jan 09 '15 | Sale | 11.87 | 31,400 | 372,661 | 1,220,283 | Jan 12 |
| Christensen Christopher R. | Director | Jan 08 '15 | Sale | 11.90 | 62,487 | 743,370 | 1,251,683 | Jan 12 |
| Christensen Christopher R. | Director | Jan 07 '15 | Sale | 11.80 | 30,078 | 355,002 | 1,314,170 | Jan 07 |
| Christensen Christopher R. | Director | Jan 06 '15 | Sale | 11.63 | 58,221 | 677,110 | 1,344,248 | Jan 07 |
| Christensen Christopher R. | Director | Jan 05 '15 | Sale | 11.78 | 26,701 | 314,564 | 1,402,469 | Jan 07 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.